Search: onr:"swepub:oai:gup.ub.gu.se/167405" > What PASSes for goo...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03422naa a2200325 4500 | |
001 | oai:lup.lub.lu.se:6aa6d2d7-91f8-4d95-a337-026045709a39 | |
003 | SwePub | |
008 | 160418s2016 | |||||||||||000 ||eng| | |
024 | 7 | a https://lup.lub.lu.se/record/6aa6d2d7-91f8-4d95-a337-026045709a392 URI |
024 | 7 | a https://doi.org/10.3109/03009742.2016.11439652 DOI |
040 | a (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a art2 swepub-publicationtype |
072 | 7 | a ref2 swepub-contenttype |
100 | 1 | a Cooper, A4 aut |
245 | 1 0 | a What PASSes for good? : Experience-based Swedish and hypothetical British EuroQol 5-Dimensions preference sets yield markedly different point estimates and patient acceptable symptom state cut-off values in chronic arthritis patients on TNF blockade |
264 | c 2016-03-30 | |
264 | 1 | b Informa UK Limited,c 2016 |
300 | a 4 s. | |
520 | a OBJECTIVES: Health utilities derived from answers to generic health-related quality of life (HRQoL) questionnaires such as the EuroQol 5-Dimensions (EQ-5D) are often used in cost-utility analyses (CUAs) of new and expensive treatments. Different preference sets (tariffs) used in the computation of utility values and quality-adjusted life-years (QALYs) from questionnaire responses (health states) yield varying results, potentially affecting decisions of resource allocation. The objective of the present study was to compare British (UK), hypothetical, and Swedish (SE), experience-based, EQ-5D utilities using data from clinical practice.METHOD: UK and SE EQ-5D utilities were computed in an observational cohort of patients with rheumatoid arthritis (RA), spondyloarthritis (SpA), and psoriatic arthritis (PsA) treated with tumour necrosis factor (TNF) blockers, comparing point estimates and patient acceptable symptom state (PASS) cut-off levels.RESULTS: SE utilities were found to be consistently higher than UK utilities, and PASS cut-offs were essentially stable over time.CONCLUSIONS: With higher baseline utilities, there may be less room for improvement after an intervention and thus less accumulation of QALYs in CUAs applying the SE, as opposed to the UK, EQ-5D tariff. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Reumatologi och inflammation0 (SwePub)302102 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Rheumatology and Autoimmunity0 (SwePub)302102 hsv//eng |
700 | 1 | a KARLSSON WALLMAN, JOHANu Lund University,Lunds universitet,Reumatologi och molekylär skelettbiologi,Sektion III,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Rheumatology,Section III,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)med-jnk |
700 | 1 | a Gülfe, Au Lund University,Lunds universitet,Reumatologi och molekylär skelettbiologi,Sektion III,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Rheumatology,Section III,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)med-agf |
710 | 2 | a Reumatologi och molekylär skelettbiologib Sektion III4 org |
773 | 0 | t Scandinavian Journal of Rheumatologyd : Informa UK Limitedg 45:6, s. 470-473q 45:6<470-473x 1502-7732x 0300-9742 |
856 | 4 | u http://dx.doi.org/10.3109/03009742.2016.1143965y FULLTEXT |
856 | 4 8 | u https://lup.lub.lu.se/record/6aa6d2d7-91f8-4d95-a337-026045709a39 |
856 | 4 8 | u https://doi.org/10.3109/03009742.2016.1143965 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.